SHAREHOLDER ALERT: WeissLaw LLP Reminds CORE, ALTA, ARPO, and ONDS Shareholders About Its Ongoing Investigations
Get Alerts CORE Hot Sheet
Join SI Premium – FREE
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) --
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
[email protected]
Core-Mark Holding Company, Inc. (NASDAQ: CORE)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Core-Mark Holding Company, Inc. (NASDAQ: CORE) in connection with the company’s proposed acquisition by Performance Food Group Company (“PFG”). Pursuant to the merger agreement, Core-Mark’s shareholders will receive $23.875 in cash and 0.44 PFG shares for each Core-Mark share they own, representing implied per-share merger consideration of approximately $45.69 based upon PFG’s May 25, 2021 closing price of $49.59. The transaction is valued at approximately $2.5 billion. If you own CORE shares and wish to discuss this investigation or your rights, please call us or visit our website: https://weisslawllp.com/core/
Altabancorp (NASDAQ: ALTA)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Altabancorp (NASDAQ: ALTA) in connection with the company’s proposed merger with Glacier Bancorp, Inc. (“Glacier”). Pursuant to the merger agreement, ALTA shareholders will receive 0.7971 shares of Glacier stock for each ALTA share they own, representing implied per-share merger consideration of approximately $45.36 based upon Glacier’s May 25, 2021 closing price of $56.91. If you own ALTA shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslawllp.com/alta/
Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO) in connection with the proposed merger of the company with privately-held Aadi Bioscience, Inc. Pursuant to the merger agreement, the two companies will combine their businesses in an all-stock transaction that will result in one combined entity that will trade publicly on the NASDAQ. If you own ARPO shares and wish to discuss this investigation or your rights, please call us or visit our website: https://weisslawllp.com/arpo/
Ondas Holdings Inc. (NASDAQ: ONDS)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Ondas Holdings Inc. (NASDAQ: ONDS) in connection with the company’s proposed acquisition of American Robotics, Inc. in a mixed cash-and-stock transaction. Pursuant to the merger agreement, ONDS will acquire American Robotics for (a) cash consideration of approximately $7,500,000, (b) 6,750,000 shares of ONDS common stock, (c) warrants exercisable for 1,875,000 shares of ONDS common stock, and (d) a potential cash payment released to ONDS stockholders from the company’s PPP Loan Escrow Amount. If you own ONDS shares and wish to discuss this investigation or your rights, please call us or visit our website: https://weisslawllp.com/news/onds/
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cumulus Announces Selected Preliminary Operating Results for First Quarter 2024
- Vipshop Filed 2023 Annual Report on Form 20-F
- Raceway Kia of Freehold Earns Prestigious Kia President's Club Award for Second Consecutive Year
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!